Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The gene array analysis of BAC and adenocarcinoma showed a transient up-regulation of Dicer (a key effector protein for small interfering RNA and miR function) and PACT along with down-regulation of most genes encoding miR machinery proteins.
|
17332367 |
2007 |
Adult-Onset Dystonias
|
0.300 |
Biomarker
|
disease |
CTD_human |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
18243799 |
2008 |
Adult-Onset Idiopathic Focal Dystonias
|
0.300 |
Biomarker
|
disease |
CTD_human |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
18243799 |
2008 |
Adult-Onset Idiopathic Torsion Dystonias
|
0.300 |
Biomarker
|
disease |
CTD_human |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
18243799 |
2008 |
Advanced lung cancer
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The aim of the PACT study is to identify the information and decision support needs of patients, leading to the development of an intervention to support patients with advanced lung cancer when considering treatment options.
|
28706092 |
2017 |
Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
We showed that PACT and pPKR colocalizations are enhanced in AD brains.
|
21790829 |
2012 |
Arteriopathic disease
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
|
29050631 |
2017 |
Arteriopathic disease
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The IN.PACT Global Study is an international single-arm study that enrolled 1,535 patients with symptomatic femoropopliteal artery disease.
|
30846089 |
2019 |
Atrial Fibrillation
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
An observational descriptive real-life epidemiological study used three validated questionnaires (EQ-5D, PACT-Q2, and MMAS-8 French Translation) to assess quality of life, treatment satisfaction, and adherence, respectively, in 200 patients managed on an outpatient basis for atrial fibrillation who were receiving anticoagulation therapy by VKA or DOAC for at least 3 months.
|
29379275 |
2018 |
Atrial Fibrillation
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Background The multicenter, single-blind, randomized EU-PACT trial compared the safety and efficacy of genotype-guided and non-genetic dosing algorithms for acenocoumarol and phenprocoumon in patients with atrial fibrillation or deep vein thrombosis.
|
28063245 |
2017 |
Autoimmune Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
Together, our findings indicate a possible role of PACT in regulating the Cardiovirus-triggered immune responses mediated by MDA5 and LGP2, which opens the door to novel therapeutic strategies in interferon-related autoimmune diseases and cancer.
|
29032202 |
2017 |
Autosomal Dominant Familial Dystonia
|
0.300 |
Biomarker
|
disease |
CTD_human |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
18243799 |
2008 |
Autosomal Dominant Juvenile Parkinson Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
18243799 |
2008 |
Autosomal Dominant Parkinsonism
|
0.300 |
Biomarker
|
disease |
CTD_human |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
18243799 |
2008 |
Autosomal Recessive Familial Dystonia
|
0.300 |
Biomarker
|
disease |
CTD_human |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
18243799 |
2008 |
Autosomal Recessive Parkinsonism
|
0.300 |
Biomarker
|
disease |
CTD_human |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
18243799 |
2008 |
Basal Ganglia Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Recently, a novel form of dystonia-parkinsonism (DYT16) has been found to be linked to mutations in the PRKRA gene, whose relation to basal ganglia disorders is yet unknown .
|
20590807 |
2010 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |
Bradykinesia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: The PACT study.
|
31067223 |
2019 |
Bronchioloalveolar Adenocarcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The gene array analysis of BAC and adenocarcinoma showed a transient up-regulation of Dicer (a key effector protein for small interfering RNA and miR function) and PACT along with down-regulation of most genes encoding miR machinery proteins.
|
17332367 |
2007 |
Carcinoma, Ovarian Epithelial
|
0.010 |
Biomarker
|
disease |
BEFREE |
<i>PRKRA</i>/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer.
|
30305341 |
2019 |
Cardiovirus Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
PACT is required for MDA5-mediated immunoresponses triggered by Cardiovirus infection via interaction with LGP2.
|
29032202 |
2017 |
Childhood Onset Dystonias
|
0.300 |
Biomarker
|
disease |
CTD_human |
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
|
18243799 |
2008 |
Clumsiness - motor delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|